Coronary Endothelial Dysfunction Is Associated With an Increased Risk of Cerebrovascular Events

Background—Stroke, mainly attributable to atherothrombotic disease, represents a leading cause of disability and death in the Western world. Endothelial dysfunction, which is considered a key factor in atherogenesis, is associated with an increased risk of cardiovascular events. However, the magnitude of the association between coronary endothelial dysfunction (CED) and cerebrovascular events is unknown. This study was performed to investigate the association between CED and cerebrovascular events. Methods and Results—We studied 503 patients without obstructive coronary artery disease (CAD) who underwent coronary endothelial function testing by intracoronary acetylcholine infusion. Patients were divided according to the presence (n=305) or absence (n=198) of CED, and medical records were examined for the occurrence of ischemic or hemorrhagic stroke or transient ischemic attack either before (prevalent) or after (incident) coronary endothelial function testing. Among the study population, a total of 25 cerebrovascular events were documented, 22 in patients with CED (15 prevalent) and 3 in patients without (all prevalent) (P =0.008). Multivariable logistic regression, which included traditional cerebrovascular disease–related risk factors, identified the presence of CED as the single strongest factor associated with cerebrovascular events (OR, 4.32; 95% CI, 1.26 to 14.83). Kaplan-Meier analysis indicated that patients with CED had a significantly higher cumulative cerebrovascular event rate than those without (P =0.04). Conclusions—Presence of CED in patients without obstructive CAD is independently associated with an increased risk of cerebrovascular events. Thus, detection of this early stage of atherosclerosis may provide important information to identify patients who benefit from aggressive preventive strategies.

[1]  P. F. Adams,et al.  Current estimates from the National Health Interview Survey, 1996. , 1999, Vital and health statistics. Series 10, Data from the National Health Survey.

[2]  T. Anderson,et al.  Assessment and treatment of endothelial dysfunction in humans. , 1999, Journal of the American College of Cardiology.

[3]  A M Zeiher,et al.  Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease. , 2000, Circulation.

[4]  A. Quyyumi,et al.  Aspirin improves endothelial dysfunction in atherosclerosis. , 1998, Circulation.

[5]  P. Wolf,et al.  Manifestations of coronary disease predisposing to stroke. The Framingham study. , 1983, JAMA.

[6]  S. Jack,et al.  Current estimates from the National Health Interview Survey. , 1981, Vital and health statistics. Series 10, Data from the National Health Survey.

[7]  A. Zeiher,et al.  Prognostic implications of endothelial dysfunction: does it mean anything? , 2001, Coronary artery disease.

[8]  F. Perticone,et al.  Prognostic Significance of Endothelial Dysfunction in Hypertensive Patients , 2001, Circulation.

[9]  L. Melton,et al.  History of the Rochester Epidemiology Project. , 1996, Mayo Clinic proceedings.

[10]  R. Gibbons,et al.  Coronary endothelial dysfunction in humans is associated with myocardial perfusion defects. , 1997, Circulation.

[11]  D. Green,et al.  Simvastatin, an HMG-coenzyme A reductase inhibitor, improves endothelial function within 1 month. , 1997, Circulation.

[12]  P. F. Adams,et al.  Current estimates from the National Health Interview Survey, 1991. , 1992, Vital and health statistics. Series 10, Data from the National Health Survey.

[13]  M. Watkins,et al.  Risk Stratification for Postoperative Cardiovascular Events via Noninvasive Assessment of Endothelial Function: A Prospective Study , 2002, Circulation.

[14]  C. Dickinson Why are strokes related to hypertension? Classic studies and hypotheses revisited. , 2001, Journal of hypertension.

[15]  A. Quyyumi,et al.  Prognostic Value of Coronary Vascular Endothelial Dysfunction , 2002, Circulation.

[16]  R. Klein,et al.  Cerebral white matter lesions, retinopathy, and incident clinical stroke. , 2002, JAMA.

[17]  G. B. John Mancini,et al.  Angiotensin Converting Enzyme Inhibition, with Quinapril, Improves Endothelial Vasomotor Dysfunction in Patients with Coronary Artery Disease: the TREND Study (Trial on REversing ENdothelial Dysfunction) , 1996 .

[18]  T. Meinertz,et al.  Endothelial Dysfunction, Oxidative Stress, and Risk of Cardiovascular Events in Patients With Coronary Artery Disease , 2001, Circulation.

[19]  K. Williams,et al.  Atherosclerosis--an inflammatory disease. , 1999, The New England journal of medicine.

[20]  P. Ganz,et al.  Systemic nature of endothelial dysfunction in atherosclerosis. , 1995, The American journal of cardiology.

[21]  S. Higano,et al.  Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction. , 2000, Circulation.